Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Darcy Krueger, MD, PhD
Children's Hospital Medical Center, Cincinnati
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California at Los Angeles
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- University of Texas at Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2015
- Primary completion
- 31 Dec 2025
- Completion
- 31 Dec 2026
- Last update posted
- 6 Aug 2026
- Registered enrollment
- 205
- Registry id
- NCT02461459
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.